journal article·2024-12-31Open access

Synthesis, Anti-Inflammatory Activity, and Docking Simulation of a Novel Styryl Quinolinium Derivative

Mina Todorova, Rumyana Bakalska, Mehran Feizi-Dehnayebi, Ghodsi Mohammadi Ziarani, Mina Pencheva, Kirila Stojnova, Miglena Milusheva, Paraskev Nedialkov, Emiliya Cherneva, Tsonko Kolev, Stoyanka Nikolova

Applied Sciences· Volume 15· Issue 1

Abstract

Stilbenes, like resveratrol, are natural small molecules with several applications in the treatment of chronic illnesses, diabetes, and neurological and cardiovascular conditions. Considering the molecular structure of stilbenes and the biological activities of resveratrol, we investigated the synthesis and biological activity of a novel styryl quinolinium (SQ) derivative. The SQ was synthesized using the alkylation of lepidine and methyl 4-methylbenzenesulfonate and further Knoevenagel condensation with 2-hydroxy naphthaldehyde. Its structure was determined using NMR, IR, Raman, UV-Vis, and MS. The current trend of research has shifted toward the synthesis of novel SQ as resveratrol’s analog. Therefore, its anti-inflammatory and antioxidant activities were evaluated. The compound exerted very good anti-inflammatory effects in preventing albumin denaturation, which were confirmed by ex vivo immunohistochemical studies. Density functional theory (DFT) analyses were conducted on the SQ structure to gain detailed insights into its active sites, energy gap, quantum properties, and electronic behavior. The biological evaluation of the compound was completed, assessing its antioxidant potential using DPPH radical scavenging assay. In addition, molecular docking simulations were utilized to assess the SQ compound’s potential inhibitory effect on human serum albumin (HSA).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Synthesis and Biological Evaluation · Bioactive Compounds and Antitumor Agents · Synthesis and biological activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria

Department of Organic Chemistry, Faculty of Chemistry, Alzahra University, Tehran 19938-93973, Iran

Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria

Department of General and Inorganic Chemistry with Methodology of Chemistry Education, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria

Department of Bioorganic Chemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria

Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria

Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria

Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., build. 9, 1113 Sofia, Bulgaria

Institute of Molecular Biology “R. Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl. 21, 1113 Sofia, Bulgaria

References (76)

Show source-provided references
1. Mitochondrial control of inflammation10.1038/s41577-022-00760-x ↗
2. Nunes, C.D.R., Barreto Arantes, M., Menezes de Faria Pereira, S., Leandro da Cruz, L., de Souza Passos, M., Pereira de Moraes, L., Vieira, I.J.C., and Barros de Oliveira, D. (2020). Plants as Sources of Anti-Inflammatory Agents. Molecules, 25.10.3390/molecules25163726 ↗
3. A review on anti-inflammatory activity of monoterpenes10.3390/molecules18011227 ↗
4. Mediatory ogólnoustrojowej odpowiedzi zapalnej—Znaczenie w praktyce klinicznej intensywnej terapii
5. Effect of resveratrol and pterostilbene on aging and longevity10.1002/biof.1400 ↗
6. Resveratrol and pterostilbene: A comparative overview of their chemistry, biosynthesis, plant sources and pharmacological properties10.7324/JAPS.2019.90717 ↗
7. Artasensi, A., Alessandro, P., Vistoli, G., and Fumagalli, L. (2020). Type 2 diabetes mellitus: A review of multi-target drugs. Molecules, 25.10.3390/molecules25081987 ↗
8. Choi, J.W., Kim, G.J., Kim, H.J., Nam, J.-W., Kim, J., Chin, J., Park, J.-H., Choi, H., and Park, K.D. (2020). Identification and evaluation of a napyradiomycin as a potent Nrf2 activator: Anti-oxidative and anti-inflammatory activities. Bioorg. Chem., 105.10.1016/j.bioorg.2020.104434 ↗
9. Wu, P.-S., Li, Y.-S., Kuo, Y.-C., Tsai, S.-J.J., and Lin, C.-C. (2019). Preparation and evaluation of novel transfersomes combined with the natural antioxidant resveratrol. Molecules, 24.10.3390/molecules24030600 ↗
10. Wine alcohol, platelets, and the French paradox for coronary heart disease10.1016/0140-6736(92)91277-F ↗
11. Chemistry and biology of resveratrol-derived natural products10.1021/cr500689b ↗
12. Akinwumi, B.C., Bordun, K.M., and Anderson, H.D. (2018). Biological activities of stilbenoids. Int. J. Mol. Sci., 19.10.3390/ijms19030792 ↗
13. Trans-, cis-, and dihydro-resveratrol: A comparative study10.1186/1752-153X-5-88 ↗
14. Comparative studies of the antioxidant effects of cis- and trans-resveratrol10.2174/092986706775197962 ↗
15. Salehi, B., Mishra, A.P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P.V.T., Martins, N., and Sharifi-Rad, J. (2018). Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines, 63.10.3390/biomedicines6030091 ↗
16. Meng, X., Zhou, J., Zhao, C.N., Gan, R.Y., and Li, H.B. (2020). Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review. Foods, 9.10.3390/foods9030340 ↗
17. Zhang, L.X., Li, C.X., Kakar, M.U., Khan, M.S., Wu, P.F., Amir, R.M., Dai, D.F., Naveed, M., Li, Q.Y., and Saeed, M. (2021). Resveratrol (RV): A pharmacological review and call for further research. Biomed. Pharmacother., 143.10.1016/j.biopha.2021.112164 ↗
18. Hassan, M., Abbasib, M.A., Siddiqui, S.Z., Shahzadi, S., Raza, H., Hussain, G., Shah, S.A.A., Ashraf, M., Shahid, M., and Seo, S.Y. (2019). Designing of promising medicinal scaffolds for Alzheimer’s disease through enzyme inhibition, lead optimization, molecular docking and dynamic simulation approaches. Bioorg. Chem., 91.10.1016/j.bioorg.2019.103138 ↗
19. Abdullah, M.A., Lee, Y.-R., Mastuki, S.T., Leong, S.W., Ibrahim, W.N.W., Latif, M.A.M., Ramli, A.N.M., Aluwi, M.F.F.M., Faudzia, S.M.M., and Kim, G.-H. (2020). Development of diarylpentadienone analogues as alpha-glucosidase inhibitor: Synthesis, in vitro biological and in vivo toxicity evaluations, and molecular docking analysis. Bioorg. Chem., 104.10.1016/j.bioorg.2020.104277 ↗
20. Mphahlele, M.J., Gildenhuys, S., and Zamisa, S.J. (2021). Synthesis, Structure and Evaluation of the N-(2-Acetyl-4-(styryl)phenyl)-4-benzenesulfonamide Derivatives for Anticholinesterase and Antioxidant Activities. Crystals, 11.10.3390/cryst11040341 ↗
21. ProTox-II: A webserver for the prediction of toxicity of chemicals10.1093/nar/gky318 ↗
22. Mazumder, K., Hossain, E., Aktar, A., Mohiuddin, M., Sarkar, K.K., Biswas, B., Aziz, A., Abid, A., and Fukase, K. (2021). In Silico Analysis and Experimental Evaluation of Ester Prodrugs of Ketoprofen for Oral Delivery: With a View to Reduce Toxicity. Processes, 9.10.3390/pr9122221 ↗
23. Discriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS)10.1021/jm0010670 ↗
24. Synthesis and PASS-assisted in silico approach of some novel 2-substituted benzimidazole bearing a pyrimidine-2,4,6 (trione) system as mucomembranous protector10.4103/0975-7406.106563 ↗
25. Ekins, S., Olechno, J., and Williams, A.J. (2013). Dispensing Processes Impact Apparent Biological Activity as Determined by Computational and Statistical Analyses. PLoS ONE, 8.10.1371/journal.pone.0062325 ↗
26. Milusheva, M., Gledacheva, V., Stefanova, I., Feizi-Dehnayebi, M., Mihaylova, R., Nedialkov, P., Cherneva, E., Tumbarski, Y., Tsoneva, S., and Todorova, M. (2023). Synthesis, Molecular Docking, and Biological Evaluation of Novel Anthranilic Acid Hybrid and Its Diamides as Antispasmodics. Int. J. Mol. Sci., 24.10.3390/ijms241813855 ↗
27. Milusheva, M., Todorova, M., Gledacheva, V., Stefanova, I., Feizi-Dehnayebi, M., Pencheva, M., Nedialkov, P., Tumbarski, Y., Yanakieva, V., and Tsoneva, S. (2023). Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases. Pharmaceuticals, 16.10.3390/ph16121660 ↗
28. Flavonoid content and radical scavenging potential of extracts prepared from tobacco cultivars and waste10.1080/14786419.2014.902947 ↗
29. Docking studies on DNA-ligand interactions: Building and application of a protocol to identify the binding mode10.1021/ci9001537 ↗
30. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility10.1002/jcc.21256 ↗
31. MGL Tools (2016). 1.5. 6 (ADT)/MGL Tools 1. 6., The Scripps Research Institute.
32. Biological Activities, DFT Calculations, and Molecular Docking Simulation of Thymol-Based Compounds
33. Cyanines during the 1990s: A review10.1021/cr990402t ↗
34. Aminoglycoside hybrids as potent RNA antagonists10.1016/S0040-4020(99)00240-9 ↗
35. Crystal and solution structures of photochromic spirobenzothiopyran. First full characterization of the meta-stable colored species10.1021/jo011011t ↗
36. Linearly polarized IR spectroscopy: Theory and applications for structural analysis
37. Synthesis, crystal structure, and spectroscopic properties of new stilbazolium salt with enlarged π-conjugated system10.1016/j.saa.2013.01.088 ↗
38. Crystal growth, spectral, structural and optical studies of π-conjugated stilbazolium crystal: 4-Bromobenzaldehyde-4′-N′-methylstilbazolium tosylate10.1016/j.saa.2014.01.029 ↗
39. Beveridge, D.L., and Lavery, R. (1991). Theoretical Biochemistry and Molecular Biophysics: A Comprehensive Survey, Adenine Press. Volume 2: Protein.
40. Structural and spectroscopic studies on 2-pyranones10.1016/j.saa.2009.10.020 ↗
41. Mohammadi Ziarani, G., Rezakhani, M., Feizi-Dehnayebi, M., and Nikolova, S. (2024). Fumed-Si-Pr-Ald-Barb as a Fluorescent Chemosensor for the Hg2+ Detection and Cr2O72− Ions: A Combined Experimental and Computational Perspective. Molecules, 29.10.3390/molecules29204825 ↗
42. Panahande, Z., Mohammadi Ziarani, G., Feizi-Dehnayebi, M., Badiei, A., and Abu-Dief, A.M. (2024). Synthesis and DFT Calculation of Hg2+ Fluorescence Chemosensor Based on a New Hybrid Organic–Inorganic Nanoporous Material of SBA-Pr-Is-Hy. Appl. Organomet. Chem., e7818.10.1002/aoc.7818 ↗
43. Design, preparation, physicochemical characterization, structural conformational, biological evaluation, and DNA interaction for some new benzimidazole complexes10.1002/aoc.7358 ↗
44. Zahirović, A., Fetahović, S., Feizi-Dehnayebi, M., Višnjevac, A., Bešta-Gajević, R., Kozarić, A., Martić, L., Topčagić, A., and Roca, S. (2024). Dual Antimicrobial-Anticancer Potential, Hydrolysis, and DNA/BSA binding affinity of a novel Water-Soluble Ruthenium-Arene ethylenediamine Schiff base (RAES) organometallic. Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 318.10.1016/j.saa.2024.124528 ↗
45. Assessment of the electrostatic binding of ferrocenylmethyl-nitroaniline derivatives to DNA: A combined experimental and theoretical study10.1016/j.molstruc.2024.138386 ↗
46. Brooker’s merocyanine: Comparison of single crystal structures10.1016/j.molstruc.2018.02.050 ↗
47. Intramolecular hydrogen bonding in derivatives of beta-alanine and gamma-amino butyric acid; model studies for the folding of unnatural polypeptide backbones10.1021/ja00082a029 ↗
48. Daina, A., Michielin, O., and Zoete, V. (2017). Swiss ADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep., 7.10.1038/srep42717 ↗
49. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings10.1016/S0169-409X(00)00129-0 ↗
50. Quantifying the chemical beauty of drugs10.1038/nchem.1243 ↗
51. A bioavailability score10.1021/jm0492002 ↗
52. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist10.2174/1389200033489253 ↗
53. In vitro adme studies of TUG-891, a GPR-120 inhibitor using Swiss adme predictor10.22270/jddt.v9i2-s.2710 ↗
54. Chronic inflam-mation: Importance of NOD2 and NALP3 in interleukin-1β generation10.1111/j.1365-2249.2006.03261.x ↗
55. Stone, M.J. (2017). Regulation of Chemokine–Receptor Interactions and Functions. Int. J. Mol. Sci., 18.10.3390/ijms18112415 ↗
56. Mast cells and histamine are triggering the NF-κB-mediated reactions of adult and aged perilymphatic mesenteric tissues to acute inflammation10.18632/aging.101113 ↗
57. Amelioration of Cognitive Impairment and Neurodegeneration by Catechin Hydrate in Rat Model of Streptozotocin-Induced Experimental Dementia of Alzheimer’s Type10.1016/j.neuint.2013.02.006 ↗
58. Antioxidant Status and Oxidative Stress Markers in Pancreatic Cancer and Chronic Pancreatitis10.1097/MPA.0b013e318288360a ↗
59. Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway10.1007/s10753-014-9942-x ↗
60. Polesso, F., Sarker, M., Anderson, A., Parker, D.C., and Murray, S.E. (2017). Constitutive expression of NF-κB inducing kinase in regulatory T cells impairs suppressive function and promotes instability and pro-inflammatory cytokine production. Sci. Rep., 7.10.1038/s41598-017-14965-x ↗
61. Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway10.1002/mc.22758 ↗
62. Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy10.1097/BOR.0000000000000054 ↗
63. Anti-inflammatory activity and structural identification of a sulfated polysaccharide CLGP4 from Caulerpa lentillifera10.1016/j.ijbiomac.2019.09.216 ↗
64. Ameliorative antibacterial, anti-inflammatory, and osteogenic activity of sulfonate-bearing polyetheretherketone toward orthopedic and dental implants10.1016/j.matlet.2021.130774 ↗
65. McEntee, C.P., Finlay, C.M., and Lavelle, E.C. (2019). Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation. Front. Immunol., 10.10.3389/fimmu.2019.01266 ↗
66. Kaminsky, L.W., Al-Sadi, R., and Ma, T.Y. (2021). IL-1β and the Intestinal Epithelial Tight Junction Barrier. Front. Immunol., 12.10.3389/fimmu.2021.767456 ↗
67. Role of interleukin-1beta during pain and inflammation10.1016/j.brainresrev.2008.12.020 ↗
68. The role of interleukin-1 in general pathology10.1186/s41232-019-0101-5 ↗
69. Adaptive Immunity in Obesity and Insulin Resistance10.1038/nrendo.2012.114 ↗
70. Impact of the Gut Microbiota on Inflammation, Obesity, and Metabolic Disease
71. Evaluation of Serum Interleukin-10 Levels as a Predictor of Glycemic Alteration in Chronic Periodontitis and Type 2 Diabetes Mellitus10.4103/0972-124X.150876 ↗
72. Effect of Cytokine Treatment on the Expression and Secretion of Brain Derived Neurotrophic Factor in the Smooth Muscle of the Rat Colon10.3892/br.2020.1302 ↗
73. IL-1β and IL-6 Excite Neurons and Suppress Nicotinic and Noradrenergic Neurotransmission in Guinea Pig Enteric Nervous System10.1172/JCI5823 ↗
74. In vitro xanthine oxidase and albumin denaturation inhibition assay of Barringtonia racemosa L. and total phenolic content analysis for potential anti-inflammatory use in gouty arthritis10.5455/jice.20160731025522 ↗
75. Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents10.1016/j.heliyon.2020.e03724 ↗
76. Frisch, M., Trucks, G., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Mennucci, B., and Petersson, G. (Gaussian 09, 2009). Gaussian 09, p. 201.